Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features
about
The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?Risk factors for etiology and prognosis of mantle cell lymphomaDo mantle cell lymphomas have an 'Achilles heel'?Racial differences in mantle cell lymphoma in the United States.SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study.Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma.Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis.DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells.Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometryBortezomib in mantle cell lymphoma: comparative therapeutic outcomesMolecular pathogenesis of mantle cell lymphoma.microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics.Clonal relationships in recurrent B-cell lymphomasPathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma.Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.Persistence of a t(11;14)-positive clone in a patient with mantle cell lymphoma for 20 years.Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group.Indolent mantle cell lymphoma.Management of mantle cell lymphoma in the elderly: current and potential strategies.Newly available antibodies with practical applications in surgical pathology.Mantle cell lymphoma--a spectrum from indolent to aggressive disease.Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.Novel targeted therapeutics for mantle cell lymphoma--what's on the horizon?Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations.Recent advances and future directions in mantle cell lymphoma research: report of the 2016 mantle cell lymphoma consortium workshop.Advances in the role of cytogenetic analysis in the molecular diagnosis of B-cell lymphomas.Which Patients With Mantle Cell Lymphoma Do Not Need Aggressive Therapy.Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma.How to manage mantle cell lymphoma.Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy.Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment.Novel agents in mantle cell lymphoma.Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan.TCL1 expression predicts overall survival in patients with mantle cell lymphoma.The role of B cell antigen receptors in mantle cell lymphoma.
P2860
Q26772907-3F9354F4-E1BE-4D66-9678-846AD3B41460Q26858960-2F695AB1-1914-4537-8907-C60916BDCAE3Q34090009-6C16D185-B30F-4DA8-B7B4-8A15ABB0A1D3Q34410264-04DBAADC-088C-4CDE-AEF1-D058A2F461D9Q34803137-BD3E0F5F-4E1E-40C6-AEE4-E8C81E2466EBQ34912276-7C70E462-6EC0-4F01-ADAC-2A35CCD468EDQ35051842-8F0A38A7-FD62-4A35-8A12-5B012B944DBEQ35492725-7E4B1DFA-B5C1-4960-906A-3265800C5CB8Q35809271-8CE040F7-43F0-428B-8CB1-86BC1B6BB46FQ36278006-18042F10-3303-45A4-B635-3A76DA4C4BD2Q36290246-3F570E83-23DC-4112-A6CC-EB1422C33CDFQ36952171-AEF7DDDC-2BFD-436D-A0FF-9C53A11D0ED3Q37022176-7CF121CB-30EB-4365-B83D-E734663715EAQ37076425-58872010-EEED-4F97-898B-2B92D449F107Q37318226-AEFF09D1-6FCA-472A-950D-01CB6B4F8CA8Q37736178-FAB651FE-3822-4B7C-8360-E194112C8760Q38110232-74D6CC16-E3E7-4C39-A936-78799846DD4CQ38127446-A66149F6-6271-4F82-AE63-28C15DD6665DQ38157682-46D75170-6B3C-4DE5-B665-F4146D188212Q38162350-18F3714D-A797-4AFE-B852-5FAA2032F4DEQ38571854-BD0EB1A0-ED5D-4BB7-977F-EDF09E9DC6C6Q38663689-5654E513-242E-44A9-9678-4856BB461078Q38675161-F05EE13E-4781-4A8E-B5E9-87AE26BA8C67Q38730980-50E2C577-EE4E-4DA6-85A7-A5C154372910Q38739035-7A3A990C-CEC8-4FC4-967B-B34DF1F3225AQ38763829-76DCCBE9-B9A1-477E-8BB5-6FA041F18F60Q38798801-F36212E3-827A-4F4E-814D-9B70D0F3E616Q38805552-AAE2F16A-6A13-49A9-8A61-D7F276838BFBQ38807612-FF0FB501-FA2E-4877-9617-55FB60214CB7Q38966407-A8C469E9-19B1-4B69-A862-8A06AA3641D5Q39029195-18E360B7-5D97-47CD-8FCB-3D64EDB850AAQ39187610-2785B88A-F3B9-4BEC-8FFA-9A7C3A2CD16CQ39225258-069174D9-678D-4EF7-B198-42AF852153B6Q39230986-B9446B24-F2F4-471F-B0AF-BD2BC78FCB04Q39290199-FD59C147-1A0D-4B04-A984-3246B7752263Q39325783-B48B240B-2524-489B-A1A2-B8516430E3F6Q39406673-EE8A3D84-CB51-4734-BC03-329D5BDA91D7Q40962764-0E17136B-A0D1-4DEA-B5CD-54A41E0937EBQ41419560-8FADA4A5-00D7-452F-AB81-0857E1086098Q42682371-BFAE0B38-E2DB-405A-8BD9-C519E9E6BA4B
P2860
Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular subsets of mantle ce ...... biologic and clinical features
@en
Molecular subsets of mantle ce ...... iologic and clinical features.
@nl
type
label
Molecular subsets of mantle ce ...... biologic and clinical features
@en
Molecular subsets of mantle ce ...... iologic and clinical features.
@nl
prefLabel
Molecular subsets of mantle ce ...... biologic and clinical features
@en
Molecular subsets of mantle ce ...... iologic and clinical features.
@nl
P2093
P2860
P50
P1433
P1476
Molecular subsets of mantle ce ...... biologic and clinical features
@en
P2093
Adrian Wiestner
Alejandra Martinez-Trillos
Anastasia Hadzidimitriou
Andreas Agathangelidis
Andreas Rosenwald
Armando Lopez-Guillermo
Birgitta Sander
Christiane Pott
Cristina Royo
P2860
P304
P356
10.1158/0008-5472.CAN-12-1615
P407
P50
P577
2012-08-20T00:00:00Z